Aino L. Ronka

Pl 100, Kys
Kuopio, 70029, Finland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 28 publications

The Long-Term Sequelae and Clinical Workload Resulting from Toxicities of Immune Checkpoint Inhibitor (ICI) Therapy in Patients with Cancer.

The Long-Term Sequelae and Clinical Workload Resulting from Toxicities of Immune Checkpoint Inhibitor (ICI) Therapy in Patients with Cancer.

Journal: Drugs - real world outcomes

Published: June 01, 2026

Evaluation of the predictive and prognostic potential of blood immune cell profiles in metastatic cancer patients treated with immune checkpoint inhibitors.

Evaluation of the predictive and prognostic potential of blood immune cell profiles in metastatic cancer patients treated with immune checkpoint inhibitors.

Journal: Cancer immunology, immunotherapy : CII

Published: March 01, 2026

Educational and regional differences in population-based incidence and survival of primary central nervous system lymphoma in Finland.

Educational and regional differences in population-based incidence and survival of primary central nervous system lymphoma in Finland.

Journal: BMC cancer

Published: August 14, 2025

Extracellular vesicles derived from pro-inflammatory M1 macrophages induce an inflammatory and invasive phenotype in melanoma cells.

Extracellular vesicles derived from pro-inflammatory M1 macrophages induce an inflammatory and invasive phenotype in melanoma cells.

Journal: Cell communication and signaling : CCS

Published: July 03, 2025

Incidence and Mortality of Mycosis Fungoides and Sezary Syndrome: A Nationwide Registry Study in Finland.

Incidence and Mortality of Mycosis Fungoides and Sezary Syndrome: A Nationwide Registry Study in Finland.

Journal: Acta dermato-venereologica

Published: June 30, 2025

Low Risk of Central Nervous System Relapse Among Patients With T-Cell/Histiocyte-Rich Large B-Cell Lymphoma Despite High-Risk Disease Presentation.

Low Risk of Central Nervous System Relapse Among Patients With T-Cell/Histiocyte-Rich Large B-Cell Lymphoma Despite High-Risk Disease Presentation.

Journal: European journal of haematology

Published: June 28, 2025

Poor survival of metastatic cancer patients hospitalized due to immune checkpoint inhibitor-related adverse events.

Poor survival of metastatic cancer patients hospitalized due to immune checkpoint inhibitor-related adverse events.

Journal: Immunotherapy

Published: April 23, 2025

Prolonged Time From Symptoms to Diagnosis Is Associated With an Inferior Progression-Free Survival in Diffuse Large B-Cell Lymphoma.

Prolonged Time From Symptoms to Diagnosis Is Associated With an Inferior Progression-Free Survival in Diffuse Large B-Cell Lymphoma.

Journal: Cancer medicine

Published: March 17, 2025

Nodal peripheral T-cell lymphoma in Finland between 2007 and 2019: Incidence, late morbidity and survival.

Nodal peripheral T-cell lymphoma in Finland between 2007 and 2019: Incidence, late morbidity and survival.

Journal: British journal of haematology

Published: February 22, 2025

Increasing incidence and prevalence of Hodgkin's lymphoma in Finland: a population-based registry study.

Increasing incidence and prevalence of Hodgkin's lymphoma in Finland: a population-based registry study.

Journal: European journal of public health

Published: January 20, 2025

Favourable Outcome of Relapsed PCNSL Among Transplant Eligble Patients.

Favourable Outcome of Relapsed PCNSL Among Transplant Eligble Patients.

Journal: European journal of haematology

Published: September 19, 2024

Defining MRI-based follow-up protocol for primary central nervous system lymphoma.

Defining MRI-based follow-up protocol for primary central nervous system lymphoma.

Journal: Annals of hematology

Published: September 09, 2024

Showing 1-12 of 28

Last Updated: 09/26/2026